Systemic reduction of S1P levels does not lead to observable effects on cell viability in control or tumor bearing mice in the syngeneic B16F10 melanoma allograft model (data not shown), perhaps suggesting the S1P rheostat requires more complete SPHK inhibition to have observable effects on cell viability. The gene discussed is MBTPS1; the disease is melanoma.